Ketamine-Morphine

PreclinicalSmall molecule

Ketamine-Morphine is one of 28 small molecule programs targeting Total Hip Arthroplasty. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Total Hip ArthroplastyActive, not recruiting

Total Hip ArthroplastyPreclinical

Active, not recruiting

Competition

Competitive Landscape

30 competitors in Total Hip Arthroplasty

#DrugCompanyPhaseTrials

Cyklokapron

JJ Molner

Approved

13 2

Fragmin

Pfizer

Approved

1 3

Naropin

FFresenius Kabi USA, LLC

Approved

9 4

Zometa

Pfizer

Approved

1 5

Medrol

Pfizer

Approved

1 6

Toradol

Roche

Approved

1 7

Decadron

AAspen Global Incorporated

Approved

5 8

Marcaine

IInnocoll

Approved

5 9

Xylocaine

MMEDRx USA, Inc.

Approved

4 10

Tylenol

KKenvue Brands

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Colorectal Surgery2 trials

PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery

Completed·UUniversiti Kebangsaan Malaysia Medical Centre·Phase 4·NCT06021717·60 enrolled

PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery.

Completed·NNational University of Malaysia·Phase 4·NCT06010056·60 enrolled

Total Hip Arthroplasty1 trial

Ketamine Associated With Morphine PCA After Total Hip Arthroplasty

Completed·AAssistance Publique - Hôpitaux de Paris·N/A·NCT00797264·18 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Ketamine-Morphine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ketamine-Morphine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ketamine-Morphine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National University of Malaysia company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational University of Malaysia

Ketamine-Morphine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Colorectal Surgery2 trials

Total Hip Arthroplasty1 trial

References

Drug Info

Quick Facts

Related News